Opinion: The FDA in the 2020s: move forward, don’t stand still
Federal regulatory agencies can’t stand still. They must evolve with industries they regulate.
No agency faces more pressure to do this than the Food and Drug Administration. Charged with simultaneously protecting the public’s health from unsafe products and promoting public health by accelerating access to new treatments, it regulates about 20 cents of each dollar in the U.S. economy, all while responding rapidly to emerging health challenges like the disease caused by the novel coronavirus, Covid-19, and new vaping technologies that may reduce risks for smokers but increase nicotine use by youth.
Read Original Article: Opinion: The FDA in the 2020s: move forward, don’t stand still »
